Research Overview

Anne B. Fulton, MD, divides her time equally between research and clinical practice. As Principal Investigator, she has had continuous NIH funding for more than 30 years. She and her laboratory group study the development of retinal and visual function in infants and children using molecular and structural approaches. She recognized the rod photoreceptors as a site of critical immaturity for infants’ vision and determined the growth curve for the rod visual pigment, rhodopsin, among other milestones, and she went on to show that rhodopsin content scales the developmental increment in dark-adapted retinal and visual sensitivity. She brought first-rate visual electrophysiology and visual psychophysics to our department, perfected the noninvasive assessments of infant and child patients, and related the normal developmental changes in retinal and visual function to the underlying biochemistry of the retina and retinal structure, including the seminal demonstration that the rhodopsin content of the retina scales retinal sensitivity in the developing human retina. More recently, she brought adaptive optics imaging to the department to provide non-invasive retinal assessments at a cellular level. Her currently funded research studies apply these procedures and concepts to the study of retinal disorders, including retinopathy of prematurity.

Research Background

Anne Fulton is a graduate of Tufts University School of Medicine. She completed an internship at Grady Memorial Hospital in Atlanta and a residency at Yale University School of Medicine.

Education

Undergraduate School

Radcliffe College
1962 Cambridge MA

Medical School

Tufts University School of Medicine
1996 Boston MA

Internship

Grady Memorial Hospital
1967 New Haven CT

Residency

Yale University School of Medicine
1976 New Haven CT

Media

Caregiver Profile

Meet Dr. Anne Fulton

Publications

  1. Characterising the refractive error in paediatric patients with congenital stationary night blindness: a multicentre study. Br J Ophthalmol. 2025 Jan 28; 109(2):286-292. View Abstract
  2. Advancing Insights into Pediatric Macular Diseases: A Comprehensive Review. J Clin Med. 2025 Jan 18; 14(2). View Abstract
  3. Evaluating the Utility of Initial Exams in Retinopathy of Prematurity: Proposal of FIRST-ROP Algorithm for a Medium-Risk Cohort. Ophthalmology. 2025 Jan 08. View Abstract
  4. HBS1L deficiency causes retinal dystrophy in a child and in a mouse model associated with defective development of photoreceptor cells. Dis Model Mech. 2024 Aug 01; 17(8). View Abstract
  5. Validation of the "TWO-ROP" Algorithm at a Multi-Neonatal Intensive Care Unit Tertiary Referral Center. Ophthalmol Retina. 2025 Jan; 9(1):63-68. View Abstract
  6. The Surviving, Not Thriving, Photoreceptors in Patients with ABCA4 Stargardt Disease. Diagnostics (Basel). 2024 Jul 17; 14(14). View Abstract
  7. Refractive errors in patients with Bardet Biedl syndrome. Ophthalmic Genet. 2024 Oct; 45(5):435-440. View Abstract
  8. Vision Loss and Difficulty Walking in a Pediatric Sexual Assault Victim. J Neuroophthalmol. 2024 Sep 01; 44(3):e498-e499. View Abstract
  9. KEARNS-SAYRE SYNDROME MASQUERADING AS MYASTHENIA GRAVIS. Retin Cases Brief Rep. 2024 May 01; 18(3):396-399. View Abstract
  10. Ciliopathy patient variants reveal organelle-specific functions for TUBB4B in axonemal microtubules. Science. 2024 Apr 26; 384(6694):eadf5489. View Abstract
  11. Characteristics of Eyes With CRB1-Associated EOSRD/LCA: Age-Related Changes. Am J Ophthalmol. 2024 07; 263:168-178. View Abstract
  12. Genetic deficiency of ribosomal rescue factor HBS1L causes retinal dystrophy associated with Pelota and EDF1 depletion. bioRxiv. 2023 Oct 20. View Abstract
  13. A Simplified Model of Activation and Deactivation of Human Rod Phototransduction-An Electroretinographic Study. Invest Ophthalmol Vis Sci. 2023 09 01; 64(12):36. View Abstract
  14. The Development of Retinal Function and Refractive Error in Children With Retinopathy of Prematurity. Invest Ophthalmol Vis Sci. 2023 08 01; 64(11):35. View Abstract
  15. Do the retinal abnormalities in X-linked juvenile retinoschisis include impaired phototransduction? Exp Eye Res. 2023 09; 234:109591. View Abstract
  16. Non-Rigid Registration for High-Resolution Retinal Imaging. Diagnostics (Basel). 2023 Jul 06; 13(13). View Abstract
  17. Electroretinographic Responses in Retinopathy of Prematurity Treated Using Intravitreal Bevacizumab or Laser. Am J Ophthalmol. 2023 08; 252:275-285. View Abstract
  18. Microcephaly and chorioretinopathy associated with TUBGCP4: a case report and a review of the literature. Ophthalmic Genet. 2023 Dec; 44(6):585-590. View Abstract
  19. Modelling eye lengths and refractions in the periphery. Ophthalmic Physiol Opt. 2023 07; 43(4):815-826. View Abstract
  20. Insights into the genotype-phenotype relationship of ocular manifestations in Kabuki syndrome. Am J Med Genet A. 2023 05; 191(5):1325-1338. View Abstract
  21. Can Nerve Growth Factor (NGF) Be a Treatment Option for Pediatric Eye Diseases? Semin Ophthalmol. 2023 Jul; 38(5):427-432. View Abstract
  22. Membrane Frizzled-Related Protein-Related Disease Mimicking Idiopathic Intracranial Hypertension. J Neuroophthalmol. 2024 Mar 01; 44(1):e26-e28. View Abstract
  23. The relation of the multifocal electroretinographic response to macular layer volume. Doc Ophthalmol. 2022 08; 145(1):1-10. View Abstract
  24. Longitudinal Change of Refractive Error in Retinopathy of Prematurity Treated With Intravitreal Bevacizumab or Laser Photocoagulation. Am J Ophthalmol. 2022 08; 240:252-259. View Abstract
  25. The Phenotypic and Mutational Spectrum of the FHONDA Syndrome and Oculocutaneous Albinism: Similarities and Differences. Invest Ophthalmol Vis Sci. 2022 01 03; 63(1):19. View Abstract
  26. Evaluation of the Relationship Between Preferential Looking Testing and Visual Evoked Potentials as a Biomarker of Cerebral Visual Impairment. Front Hum Neurosci. 2021; 15:769259. View Abstract
  27. Broadening INPP5E phenotypic spectrum: detection of rare variants in syndromic and non-syndromic IRD. NPJ Genom Med. 2021 Jun 29; 6(1):53. View Abstract
  28. Fundus Pigmentary Whorls in a Patient With Mosaicism for Tetrasomy 3q. JAMA Ophthalmol. 2021 Jun 17. View Abstract
  29. Cerebral visual impairment in CDKL5 deficiency disorder: vision as an outcome measure. Dev Med Child Neurol. 2021 11; 63(11):1308-1315. View Abstract
  30. Artificial Intelligence (AI) Applications for Age-Related Macular Degeneration (AMD) and Other Retinal Dystrophies. Semin Ophthalmol. 2021 May 19; 36(4):304-309. View Abstract
  31. Optical Coherence Tomography Angiography in Prematurity. Semin Ophthalmol. 2021 May 19; 36(4):264-269. View Abstract
  32. Genetic causes of nystagmus, foveal hypoplasia and subnormal visual acuity- other than albinism. Ophthalmic Genet. 2021 06; 42(3):243-251. View Abstract
  33. Dark-adapted threshold and electroretinogram for diagnosis of Usher syndrome. Doc Ophthalmol. 2021 08; 143(1):39-51. View Abstract
  34. Homozygous deletion of 21q22.2 in a patient with hypotonia, developmental delay, cortical visual impairment, and retinopathy. Am J Med Genet A. 2021 02; 185(2):555-560. View Abstract
  35. Carbonic anhydrase inhibition in X-linked retinoschisis: An eye on the photoreceptors. Exp Eye Res. 2021 01; 202:108344. View Abstract
  36. The Fovea in Retinopathy of Prematurity. Invest Ophthalmol Vis Sci. 2020 09 01; 61(11):28. View Abstract
  37. Retinal Function in X-Linked Juvenile Retinoschisis. Invest Ophthalmol Vis Sci. 2019 11 01; 60(14):4872-4881. View Abstract
  38. Extracting the ON and OFF contributions to the full-field photopic flash electroretinogram using summed growth curves. Exp Eye Res. 2019 12; 189:107827. View Abstract
  39. Impact of Obstructive Sleep Apnea on Optic Nerve Function in Patients With Craniosynostosis and Recurrent Intracranial Hypertension. Am J Ophthalmol. 2019 11; 207:356-362. View Abstract
  40. Microperimetry in Three Inherited Retinal Disorders. Semin Ophthalmol. 2019; 34(4):334-339. View Abstract
  41. The migraine eye: distinct rod-driven retinal pathways' response to dim light challenges the visual cortex hyperexcitability theory. Pain. 2019 Mar; 160(3):569-578. View Abstract
  42. Neurobiology of Photophobia. J Neuroophthalmol. 2019 03; 39(1):94-102. View Abstract
  43. High prevalence of strabismic visual field expansion in pediatric homonymous hemianopia. PLoS One. 2018; 13(12):e0209213. View Abstract
  44. Color-selective photophobia in ictal vs interictal migraineurs and in healthy controls. Pain. 2018 Oct; 159(10):2030-2034. View Abstract
  45. ISCEV guide to visual electrodiagnostic procedures. Doc Ophthalmol. 2018 02; 136(1):1-26. View Abstract
  46. The importance of genetic testing as demonstrated by two cases of CACNA1F-associated retinal generation misdiagnosed as LCA. Mol Vis. 2017; 23:695-706. View Abstract
  47. Increased Survival and Partly Preserved Cognition in a Patient With ACO2-Related Disease Secondary to a Novel Variant. J Child Neurol. 2017 08; 32(9):840-845. View Abstract
  48. Juvenile Macular Degenerations. Semin Pediatr Neurol. 2017 05; 24(2):104-109. View Abstract
  49. Multifocal ERG Responses in Subjects With a History of Preterm Birth. Invest Ophthalmol Vis Sci. 2017 05 01; 58(5):2603-2608. View Abstract
  50. Progressive retinal degeneration in a girl with Knobloch syndrome who presented with signs of ocular albinism. Doc Ophthalmol. 2017 04; 134(2):135-140. View Abstract
  51. Available Evidence on Leber Congenital Amaurosis and Gene Therapy. Semin Ophthalmol. 2017; 32(1):14-21. View Abstract
  52. The neural retina in retinopathy of prematurity. Prog Retin Eye Res. 2017 01; 56:32-57. View Abstract
  53. Reduced Left Lateralization of Language in Congenitally Blind Individuals. J Cogn Neurosci. 2017 Jan; 29(1):65-78. View Abstract
  54. Retinal, visual, and refractive development in retinopathy of prematurity. Eye Brain. 2016; 8:103-111. View Abstract
  55. Migraine photophobia originating in cone-driven retinal pathways. Brain. 2016 07; 139(Pt 7):1971-86. View Abstract
  56. Increment Threshold Functions in Retinopathy of Prematurity. Invest Ophthalmol Vis Sci. 2016 05 01; 57(6):2421-7. View Abstract
  57. Expansion of phenotype and genotypic data in CRB2-related syndrome. Eur J Hum Genet. 2016 10; 24(10):1436-44. View Abstract
  58. Differentiation of murine models of "negative ERG" by single and repetitive light stimuli. Doc Ophthalmol. 2016 Apr; 132(2):101-9. View Abstract
  59. Extrafoveal Cone Packing in Eyes With a History of Retinopathy of Prematurity. Invest Ophthalmol Vis Sci. 2016 Feb; 57(2):467-75. View Abstract
  60. Eye growth in term- and preterm-born eyes modeled from magnetic resonance images. Invest Ophthalmol Vis Sci. 2015 May; 56(5):3121-31. View Abstract
  61. Vigabatrin can enhance electroretinographic responses in pigmented and albino rats. Doc Ophthalmol. 2015 Aug; 131(1):1-11. View Abstract
  62. Temporal summation in children with a history of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2015 Jan 20; 56(2):914-7. View Abstract
  63. Panel-based genetic diagnostic testing for inherited eye diseases is highly accurate and reproducible, and more sensitive for variant detection, than exome sequencing. Genet Med. 2015 Apr; 17(4):253-261. View Abstract
  64. Effect of retinopathy of prematurity on scotopic spatial summation. Invest Ophthalmol Vis Sci. 2014 Apr 29; 55(5):3311-3. View Abstract
  65. The rat with oxygen-induced retinopathy is myopic with low retinal dopamine. Invest Ophthalmol Vis Sci. 2013 Dec 19; 54(13):8275-84. View Abstract
  66. The hermansky-pudlak syndrome: clinical features and imperatives from an ophthalmic perspective. Semin Ophthalmol. 2013 Sep-Nov; 28(5-6):387-91. View Abstract
  67. CRB1: one gene, many phenotypes. Semin Ophthalmol. 2013 Sep-Nov; 28(5-6):397-405. View Abstract
  68. Introduction to the special issue: vision after premature birth. Doc Ophthalmol. 2013 Aug; 127(1):1-2. View Abstract
  69. Photoreceptor and postreceptor responses in congenital stationary night blindness. Invest Ophthalmol Vis Sci. 2013 Jul 10; 54(7):4648-58. View Abstract
  70. Next-generation sequencing analysis of gene regulation in the rat model of retinopathy of prematurity. Doc Ophthalmol. 2013 Aug; 127(1):13-31. View Abstract
  71. Alterations of the tunica vasculosa lentis in the rat model of retinopathy of prematurity. Doc Ophthalmol. 2013 Aug; 127(1):3-11. View Abstract
  72. Multimodal adaptive optics retinal imager: design and performance. J Opt Soc Am A Opt Image Sci Vis. 2012 Dec 01; 29(12):2598-607. View Abstract
  73. Electroretinographic (ERG) responses in pediatric patients using vigabatrin. Doc Ophthalmol. 2012 Jun; 124(3):197-209. View Abstract
  74. Effect of carotenoid supplementation on plasma carotenoids, inflammation and visual development in preterm infants. J Perinatol. 2012 Jun; 32(6):418-24. View Abstract
  75. Variations in NPHP5 in patients with nonsyndromic leber congenital amaurosis and Senior-Loken syndrome. Arch Ophthalmol. 2011 Jan; 129(1):81-7. View Abstract
  76. Long-term effects of retinopathy of prematurity (ROP) on rod and rod-driven function. Doc Ophthalmol. 2011 Feb; 122(1):19-27. View Abstract
  77. Cone ERG responses in patients with Smith-Lemli-Opitz Syndrome (SLOS). Doc Ophthalmol. 2010 Oct; 121(2):85-91. View Abstract
  78. Visual cycle modulation in neurovascular retinopathy. Exp Eye Res. 2010 Aug; 91(2):153-61. View Abstract
  79. Deactivation of the rod response in retinopathy of prematurity. Doc Ophthalmol. 2010 Aug; 121(1):29-35. View Abstract
  80. Editorial for special issue: rat models of ROP. Doc Ophthalmol. 2010 Feb; 120(1):1-2. View Abstract
  81. Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial. Lancet. 2009 Nov 07; 374(9701):1597-605. View Abstract
  82. The anatomy of the rat eye with oxygen-induced retinopathy. Doc Ophthalmol. 2010 Feb; 120(1):41-50. View Abstract
  83. The neurovascular retina in retinopathy of prematurity. Prog Retin Eye Res. 2009 Nov; 28(6):452-82. View Abstract
  84. Visual fields in young children treated with vigabatrin. Optom Vis Sci. 2009 Jun; 86(6):767-73. View Abstract
  85. Development of rod function in term born and former preterm subjects. Optom Vis Sci. 2009 Jun; 86(6):E653-8. View Abstract
  86. The neurovascular relation in oxygen-induced retinopathy. Mol Vis. 2008; 14:2499-508. View Abstract
  87. ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol. 2009 Feb; 118(1):69-77. View Abstract
  88. Rod and rod-driven function in achromatopsia and blue cone monochromatism. Invest Ophthalmol Vis Sci. 2009 Feb; 50(2):950-8. View Abstract
  89. Synergistic interaction of the OCA2 and OCA3 genes in a family. Am J Med Genet A. 2008 Sep 15; 146A(18):2427-30. View Abstract
  90. Multifocal ERG responses in infants. Invest Ophthalmol Vis Sci. 2009 Jan; 50(1):470-5. View Abstract
  91. Retinal degenerative and hypoxic ischemic disease. Doc Ophthalmol. 2009 Feb; 118(1):55-61. View Abstract
  92. The cone electroretinogram in retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2008 Feb; 49(2):814-9. View Abstract
  93. Foveal fine structure in retinopathy of prematurity: an adaptive optics Fourier domain optical coherence tomography study. Invest Ophthalmol Vis Sci. 2008 May; 49(5):2061-70. View Abstract
  94. The oscillatory potentials of the dark-adapted electroretinogram in retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2007 Dec; 48(12):5788-97. View Abstract
  95. Effects of desferoxamine on retinal and visual function. Arch Ophthalmol. 2007 Nov; 125(11):1581-2. View Abstract
  96. Development of scotopic visual thresholds in retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2007 Oct; 48(10):4854-60. View Abstract
  97. The genetics and ocular findings of Alagille syndrome. Semin Ophthalmol. 2007 Oct-Dec; 22(4):205-10. View Abstract
  98. Rod photoreceptor function predicts blood vessel abnormality in retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2007 Sep; 48(9):4351-9. View Abstract
  99. Retinal degeneration in children: dark adapted visual threshold and arteriolar diameter. Vision Res. 2008 Feb; 48(3):325-31. View Abstract
  100. Development of the electroretinographic oscillatory potentials in normal and ROP rats. Invest Ophthalmol Vis Sci. 2006 Dec; 47(12):5447-52. View Abstract
  101. Pediatric clinical visual electrophysiology: a survey of actual practice. Doc Ophthalmol. 2006 Nov; 113(3):193-204. View Abstract
  102. The retinal vasculature and function of the neural retina in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2006 Jun; 47(6):2639-47. View Abstract
  103. Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California). Mol Vis. 2006 May 23; 12:532-80. View Abstract
  104. Multifocal ERG in subjects with a history of retinopathy of prematurity. Doc Ophthalmol. 2005 Jul; 111(1):7-13. View Abstract
  105. X-linked creatine transporter defect: a report on two unrelated boys with a severe clinical phenotype. J Inherit Metab Dis. 2006 Feb; 29(1):214-9. View Abstract
  106. Diagnosis of plus disease in retinopathy of prematurity using Retinal Image multiScale Analysis. Invest Ophthalmol Vis Sci. 2005 Dec; 46(12):4734-8. View Abstract
  107. Development of the cone ERG in infants. Invest Ophthalmol Vis Sci. 2005 Sep; 46(9):3458-62. View Abstract
  108. Development of visual acuity in children with cerebral visual impairment. Arch Ophthalmol. 2005 Sep; 123(9):1215-20. View Abstract
  109. Maculopathy and retinal degeneration in cobalamin C methylmalonic aciduria and homocystinuria. Arch Ophthalmol. 2005 Aug; 123(8):1143-6. View Abstract
  110. Early ametropia and rod photoreceptor function in retinopathy of prematurity. Optom Vis Sci. 2005 Apr; 82(4):307-17. View Abstract
  111. ERG oscillatory potentials in infants. Doc Ophthalmol. 2005 Mar-May; 110(2-3):265-70. View Abstract
  112. Recovery of the rod photoresponse in infants. Invest Ophthalmol Vis Sci. 2005 Feb; 46(2):764-8. View Abstract
  113. Comparison of ERGs recorded with skin and corneal-contact electrodes in normal children and adults. Doc Ophthalmol. 2004 Jul; 109(1):43-55. View Abstract
  114. Recovery of the rod photoresponse in infant rats. Vision Res. 2003 Dec; 43(28):3081-5. View Abstract
  115. Rod photoreceptor responses in children with Smith-Lemli-Opitz syndrome. Arch Ophthalmol. 2003 Dec; 121(12):1738-43. View Abstract
  116. Development of ERG responses: the ISCEV rod, maximal and cone responses in normal subjects. Doc Ophthalmol. 2003 Nov; 107(3):235-41. View Abstract
  117. Effects of telazol and nembutal on retinal responses. Doc Ophthalmol. 2003 Jul; 107(1):45-51. View Abstract
  118. Retinal function in carriers of Bardet-Biedl syndrome. Arch Ophthalmol. 2003 Jun; 121(6):804-10. View Abstract
  119. Evaluation of complex inheritance involving the most common Bardet-Biedl syndrome locus (BBS1). Am J Hum Genet. 2003 Feb; 72(2):429-37. View Abstract
  120. Rod photoreceptor function in children with mitochondrial disorders. Arch Ophthalmol. 2002 Aug; 120(8):1055-62. View Abstract
  121. Identification of the gene (BBS1) most commonly involved in Bardet-Biedl syndrome, a complex human obesity syndrome. Nat Genet. 2002 Aug; 31(4):435-8. View Abstract
  122. Fundus photography for measurement of macular pigment density distribution in children. Invest Ophthalmol Vis Sci. 2002 May; 43(5):1450-5. View Abstract
  123. Background adaptation in a rat model of retinopathy of prematurity. Doc Ophthalmol. 2002 Jan; 104(1):97-105. View Abstract
  124. Novel frameshift mutations in CRX associated with Leber congenital amaurosis. Hum Mutat. 2001 Dec; 18(6):550-1. View Abstract
  125. Cycloplegic refractions in healthy children aged 1 through 48 months. Arch Ophthalmol. 2001 Nov; 119(11):1625-8. View Abstract
  126. Positional cloning of a novel gene on chromosome 16q causing Bardet-Biedl syndrome (BBS2). Hum Mol Genet. 2001 Apr 01; 10(8):865-74. View Abstract
  127. The rod photoreceptors in retinopathy of prematurity: an electroretinographic study. Arch Ophthalmol. 2001 Apr; 119(4):499-505. View Abstract
  128. Mutations in the CRB1 gene cause Leber congenital amaurosis. Arch Ophthalmol. 2001 Mar; 119(3):415-20. View Abstract
  129. Cortical visual impairment in infants and children. Int Ophthalmol Clin. 2001; 41(1):159-69. View Abstract
  130. Rod-mediated increment threshold functions in infants. Invest Ophthalmol Vis Sci. 2000 Dec; 41(13):4347-52. View Abstract
  131. The development of scotopic sensitivity. Invest Ophthalmol Vis Sci. 2000 May; 41(6):1588-96. View Abstract
  132. Background adaptation in children with a history of mild retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2000 Jan; 41(1):320-4. View Abstract
  133. The rhodopsin content of human eyes. Invest Ophthalmol Vis Sci. 1999 Jul; 40(8):1878-83. View Abstract
  134. The course of maturation of rod-mediated visual thresholds in infants. Invest Ophthalmol Vis Sci. 1999 Jul; 40(8):1883-6. View Abstract
  135. Rod photoreceptor maturation does not vary with retinal eccentricity in mammalian retina. Curr Eye Res. 1999 Jun; 18(6):393-402. View Abstract
  136. Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome) [correction of (Hennansky-Pudlak)]. Arch Ophthalmol. 1999 Feb; 117(2):251-2. View Abstract
  137. Rod photoreceptors in infant rats with a history of oxygen exposure. Invest Ophthalmol Vis Sci. 1999 Jan; 40(1):168-74. View Abstract
  138. Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or leber congenital amaurosis. Proc Natl Acad Sci U S A. 1998 Mar 17; 95(6):3088-93. View Abstract
  139. Rod and rod mediated function in patients with beta-thalassemia major. Doc Ophthalmol. 1998-1999; 96(4):333-45. View Abstract
  140. Central retinal vein occlusion in a young child with cyanotic heart disease. Arch Ophthalmol. 1997 Aug; 115(8):1077. View Abstract
  141. Dark-adapted thresholds in children with histories of mild retinopathy of prematurity. Invest Ophthalmol Vis Sci. 1997 May; 38(6):1175-83. View Abstract
  142. Rhodopsin in immature rod outer segments. Invest Ophthalmol Vis Sci. 1996 Sep; 37(10):1951-6. View Abstract
  143. Vision in Leber congenital amaurosis. Arch Ophthalmol. 1996 Jun; 114(6):698-703. View Abstract
  144. Photoreceptor function in infants and children with a history of mild retinopathy of prematurity. J Opt Soc Am A Opt Image Sci Vis. 1996 Mar; 13(3):566-71. View Abstract
  145. Effect of prior oxygen exposure on the electroretinographic responses of infant rats. Invest Ophthalmol Vis Sci. 1995 Sep; 36(10):2071-9. View Abstract
  146. The effects of acetazolamide on the electroretinographic responses in rats. Invest Ophthalmol Vis Sci. 1995 May; 36(6):1019-26. View Abstract
  147. The development of the rod photoresponse from dark-adapted rats. Invest Ophthalmol Vis Sci. 1995 May; 36(6):1038-45. View Abstract
  148. The course of myopia in children with mild retinopathy of prematurity. Vision Res. 1995 May; 35(9):1329-35. View Abstract
  149. Dark-adapted thresholds at 10- and 30-deg eccentricities in 10-week-old infants. Vis Neurosci. 1995 May-Jun; 12(3):509-12. View Abstract
  150. The VEP thresholds for full-field stimuli in dark-adapted infants. Vis Neurosci. 1995 Mar-Apr; 12(2):223-8. View Abstract
  151. Electroretinogram responses and refractive errors in patients with a history of retinopathy prematurity. Doc Ophthalmol. 1995-1996; 91(2):87-100. View Abstract
  152. Scotopic optokinetic nystagmus thresholds in 10-week-old infants. Invest Ophthalmol Vis Sci. 1994 Mar; 35(3):1246-9. View Abstract
  153. Scotopic center surround organization in 10-week-old infants. Vision Res. 1994 Mar; 34(5):621-4. View Abstract
  154. Clinical physiology of heritable photoreceptor diseases. Arch Ophthalmol. 1993 Nov; 111(11):1479-81. View Abstract
  155. Natural course of visual functions in the Bardet-Biedl syndrome. Arch Ophthalmol. 1993 Nov; 111(11):1500-6. View Abstract
  156. The rod sensitivity of dark adapted human infants. Curr Eye Res. 1992 Dec; 11(12):1193-8. View Abstract
  157. Screening preschool children to detect visual and ocular disorders. Arch Ophthalmol. 1992 Nov; 110(11):1553-4. View Abstract
  158. Effects of halothane on children's electroretinograms. Ophthalmology. 1992 Aug; 99(8):1309-12. View Abstract
  159. The effect of light adaptation on scotopic spatial summation in 10-week-old infants. Vision Res. 1992 Feb; 32(2):387-92. View Abstract
  160. Albinism. Int Ophthalmol Clin. 1992; 32(1):185-200. View Abstract
  161. The quantity of rhodopsin in young human eyes. Curr Eye Res. 1991 Oct; 10(10):977-82. View Abstract
  162. Visual development of infants with severe ocular disorders. Ophthalmology. 1991 Aug; 98(8):1306-9. View Abstract
  163. Delayed visual maturation. Lancet. 1991 Jun 01; 337(8753):1350. View Abstract
  164. Dark adapted thresholds in young RCS rats. Vision Res. 1991; 31(4):637-42. View Abstract
  165. Temporal summation in dark-adapted 10-week old infants. Vision Res. 1991; 31(7-8):1259-69. View Abstract
  166. Electroretinographic assessment of background adaptation in 10-week-old human infants. Vision Res. 1991; 31(9):1501-7. View Abstract
  167. The quantity of rhodopsin in human eyes. Curr Eye Res. 1990 Dec; 9(12):1211-6. View Abstract
  168. Hyperopia in complicated Leber's congenital amaurosis. Arch Ophthalmol. 1990 May; 108(5):709-12. View Abstract
  169. Dark adaptation in hyperprolactinemic women. Invest Ophthalmol Vis Sci. 1989 Jun; 30(6):1177-80. View Abstract
  170. Electrophysiologic testing techniques for children. Doc Ophthalmol. 1989 Apr; 71(4):341-54. View Abstract
  171. Psychophysical estimates of ocular media density of human infants. Vision Res. 1989; 29(6):687-90. View Abstract
  172. Visual acuities and dark-adapted thresholds of children with Bardet-Biedl syndrome. Am J Ophthalmol. 1988 Nov 15; 106(5):561-9. View Abstract
  173. Visual fields of young children. Behav Brain Res. 1988 Jul; 29(1-2):7-16. View Abstract
  174. The development of scotopic retinal function in human infants. Doc Ophthalmol. 1988 Jun; 69(2):101-9. View Abstract
  175. Visual fields of infants assessed with a new perimetric technique. Invest Ophthalmol Vis Sci. 1988 Mar; 29(3):452-9. View Abstract
  176. Scotopic stimulus/response relations of the B-wave of the electroretinogram. Doc Ophthalmol. 1988 Mar-Apr; 68(3-4):293-304. View Abstract
  177. The relation of rhodopsin and scotopic retinal sensitivity in sector retinitis pigmentosa. Am J Ophthalmol. 1988 Feb 15; 105(2):132-40. View Abstract
  178. Optokinetic nystagmus thresholds of dark-adapted RCS rats. Vision Res. 1988; 28(7):761-4. View Abstract
  179. Esotropic children with amblyopia: effects of patching on acuity. Graefes Arch Clin Exp Ophthalmol. 1988; 226(4):309-12. View Abstract
  180. Special diagnostic and therapeutic modalities in pediatric ophthalmology. Pediatr Clin North Am. 1987 Dec; 34(6):1543-53. View Abstract
  181. The relation of rhodopsin and scotopic sensitivity in choroideremia. Am J Ophthalmol. 1987 Nov 15; 104(5):524-32. View Abstract
  182. Oscillatory potentials of visually inattentive children. Doc Ophthalmol. 1987 Mar; 65(3):319-32. View Abstract
  183. Foveal cone pigments and sensitivity in young patients with Usher's syndrome. Am J Ophthalmol. 1987 Feb 15; 103(2):150-60. View Abstract
  184. Intramuscular vitamin E repletion in children with chronic cholestasis. Am J Dis Child. 1987 Feb; 141(2):170-4. View Abstract
  185. Concurrence of congenital ocular motor apraxia and other motor problems: an expanded syndrome. Dev Med Child Neurol. 1987 Feb; 29(1):85-90. View Abstract
  186. The relationship of retinal sensitivity and rhodopsin in human infants. Vision Res. 1987; 27(5):697-704. View Abstract
  187. "Self-screening" of rhodopsin in rod outer segments. Vision Res. 1987; 27(9):1459-70. View Abstract
  188. Pupillary changes during dark adaptation in human infants. Invest Ophthalmol Vis Sci. 1986 Dec; 27(12):1726-9. View Abstract
  189. Assessment of acuity of amblyopic subjects using face, grating, and recognition stimuli. Invest Ophthalmol Vis Sci. 1986 Jul; 27(7):1184-7. View Abstract
  190. Background adaptation in human infants. Vision Res. 1986; 26(5):771-9. View Abstract
  191. Electroretinography: application to clinical studies of infants. J Pediatr Ophthalmol Strabismus. 1985 Nov-Dec; 22(6):251-5. View Abstract
  192. Assessment of young amblyopes. Array vs. single picture acuities. Ophthalmology. 1985 Sep; 92(9):1197-202. View Abstract
  193. Retinal degenerations and brain abnormalities in infants and young children. Doc Ophthalmol. 1985 Aug 30; 60(2):133-40. View Abstract
  194. Visual acuity of infants and children with retinal degenerations. Ophthalmic Paediatr Genet. 1985 Feb; 5(1-2):51-6. View Abstract
  195. Preferential looking grating acuities of infants at risk of amblyopia. Trans Ophthalmol Soc U K (1962). 1985; 104 ( Pt 8):903-11. View Abstract
  196. Grating and recognition acuities of pediatric patients. Ophthalmology. 1984 Aug; 91(8):947-53. View Abstract
  197. Assessment of acuity in human infants using face and grating stimuli. Invest Ophthalmol Vis Sci. 1984 Jul; 25(7):782-6. View Abstract
  198. The relation of retinal sensitivity and rhodopsin in developing rat retina. Invest Ophthalmol Vis Sci. 1984 Jun; 25(6):647-51. View Abstract
  199. Retinal degeneration in vitamin B12 disorder associated with methylmalonic aciduria and sulfur amino acid abnormalities. Am J Ophthalmol. 1984 Jun; 97(6):691-6. View Abstract
  200. Cycloplegic refractions of infants and young children: the axis of astigmatism. Invest Ophthalmol Vis Sci. 1984 Jan; 25(1):83-7. View Abstract
  201. Retinal sensitivity and adaptation in pediatric patients. Behav Brain Res. 1983 Oct; 10(1):59-70. View Abstract
  202. Preferential looking acuity of pediatric patients with developmental disabilities. Behav Brain Res. 1983 Oct; 10(1):189-97. View Abstract
  203. Background adaptation in RCS rats. Invest Ophthalmol Vis Sci. 1983 Jan; 24(1):72-6. View Abstract
  204. Preferential looking vision testing: application to evaluation of high-risk, prematurely born infants and children. J Pediatr Ophthalmol Strabismus. 1982 Nov-Dec; 19(6):286-93. View Abstract
  205. Preferential looking acuity obtained with a staircase procedure in pediatric patients. Invest Ophthalmol Vis Sci. 1982 Oct; 23(4):538-43. View Abstract
  206. Scotopic thresholds and plasma retinol in cystic fibrosis. Invest Ophthalmol Vis Sci. 1982 Sep; 23(3):364-70. View Abstract
  207. The relation of myopia and astigmatism in developing eyes. Ophthalmology. 1982 Apr; 89(4):298-302. View Abstract
  208. Dark-adapted sensitivity, rhodopsin content, and background adaptation in pcd/pcd mice. Invest Ophthalmol Vis Sci. 1982 Mar; 22(3):386-93. View Abstract
  209. Development of the outer plexiform layer in albino rats. Curr Eye Res. 1982-1983; 2(5):295-9. View Abstract
  210. Retinal degeneration in the delayed amelanotic (DAM) chicken: an electroretinographic study. Curr Eye Res. 1982-1983; 2(11):757-63. View Abstract
  211. Behavioral measurement of background adaptation in infants. Invest Ophthalmol Vis Sci. 1981 Oct; 21(4):625-9. View Abstract
  212. Cycloplegic refractions of premature infants. Am J Ophthalmol. 1981 Apr; 91(4):490-5. View Abstract
  213. Cone pigments in acute posterior multifocal placoid pigment epitheliopathy. Am J Ophthalmol. 1981 Apr; 91(4):465-8. View Abstract
  214. Measuring visual acuity in infants. Surv Ophthalmol. 1981 Mar-Apr; 25(5):325-32. View Abstract
  215. Cycloplegic refractions in infants and young children. Am J Ophthalmol. 1980 Aug; 90(2):239-47. View Abstract
  216. Increased incidence of choroidal malignant melanoma occurring in a single population of chemical workers. Am J Ophthalmol. 1980 Mar; 89(3):323-37. View Abstract
  217. Background adaptation in developing rat retina: an electroretinographic study. Vision Res. 1980; 20(10):819-26. View Abstract
  218. Retinal anomalies in trisomy 18. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1980; 213(3):195-205. View Abstract
  219. Epidemikological investigation of increased incidence of choroidal melanoma in a single population of chemical workers. Int Ophthalmol Clin. 1980; 20(2):71-92. View Abstract
  220. Infant vision testing by a behavioral method. Ophthalmology. 1979 Mar; 86(3):431-9. View Abstract
  221. A behavioral method for efficient screening of visual acuity in young infants. II. Clinical application. Invest Ophthalmol Vis Sci. 1978 Dec; 17(12):1151-7. View Abstract
  222. Human retinal dysplasia. Am J Ophthalmol. 1978 May; 85(5 Pt 1):690-8. View Abstract
  223. Human albinism. Light and electron microscopy study. Arch Ophthalmol. 1978 Feb; 96(2):305-10. View Abstract
  224. Rod ERG of the mudpuppy: effect of dim red backgrounds. Vision Res. 1978; 18(7):785-92. View Abstract
  225. The human rod ERG: correlation with psychophysical responses in light and dark adaptation. Vision Res. 1978; 18(7):793-800. View Abstract
  226. Ocular findings in triploidy. Am J Ophthalmol. 1977 Dec; 84(6):859-67. View Abstract
  227. Spontaneous anophthalmia and microphthalmia in white-tailed deer. J Comp Pathol. 1977 Oct; 87(4):557-68. View Abstract
  228. Comparative ophthalmic pathology. Invest Ophthalmol. 1976 Dec; 15(12):975-8. View Abstract
  229. Active giant cell arteritis with cerebral involvement. Findings following four years of corticosteroid therapy. Arch Ophthalmol. 1976 Dec; 94(12):2068-71. View Abstract
  230. Gastrointestinal sarcoidosis diagnosed by conjunctival biopsy. Am J Ophthalmol. 1976 Jul; 82(1):102-4. View Abstract
  231. Dark adaptation and the rate of pigment regeneration. Vision Res. 1969 Dec; 9(12):1473-9. View Abstract
  232. Dark adaptation: free opsin or regeneration rate? J Physiol. 1969 Oct; 204(2):124P+. View Abstract

Contact Anne Fulton